We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ecolab Disinfectant Gets EPA Nod for Use Against SARS-CoV-2
Read MoreHide Full Article
Ecolab Inc (ECL - Free Report) recently attained product approval from the U.S. Environmental Protection Agency (EPA) for use against SARS-CoV-2, the virus responsible for COVID-19.
Ecolab’s Peroxide Multi Surface Cleaner and Disinfectant is the first EPA-registered disinfectant which has been proven to be effective at killing the SARS-CoV-2 virus and has been approved for use with electrostatic spray technology. This disinfectant is one example of breakthrough solutions powering the new Ecolab Science Certified program.
This is expected to boost Ecolab’s Global Industrial segment.
More on the Product
Utilizing Ecolab’s expertise in hospital hygiene, this proficient disinfectant can be used across several environments, including hospitals, hotels and retail stores. It has been proven to be effective at killing the SARS-CoV-2 virus in only 30 seconds, in both spray bottle and electrostatic spray applications. Among all disinfectants approved for electrostatic spray use, this one is the fastest at killing viruses. No other disinfectant approved for electrostatic spray use has proven effective against the virus causing COVID-19.
When used in an electrostatic spray application, Ecolab’s Peroxide Multi Surface Cleaner and Disinfectant can disinfect large indoor spaces effectively. This industry-leading 3-in-1 peroxide hard-surface cleaner, glass cleaner and disinfectant joins Ecolab’s plethora of disinfectants registered by the EPA as proven effective against SARS-CoV-2.
Apart from this, Ecolab’s Peroxide Multi Surface Cleaner and Disinfectant is convenient to use and offers a streak-free clean across high-touch, hard surfaces and glass. When used manually, it makes the cleaning process simple and lessens the number of cleaning products needed by fusing an effective cleaner and disinfectant into one solution without the requirement to rinse between cleaning and disinfecting.
Recent Developments
This month, Ecolab launched a path-breaking product, Sink & Surface Cleaner Sanitizer, to address unexpected hygiene challenges. It is the first EPA-registered concentrated no-rinse, 2-in-1 cleaner and sanitizer for food contact surfaces that can kill emerging viral pathogens in 30 seconds.
Also recently, the company’s Synergex Sanitizer & Disinfectant became the first product to attain EPA approval for efficiency against biofilms, a complex community of bacteria on food contact surfaces.
Market Prospects
Per a report by ResearchAndMarket.com, the global disinfectants market is projected to rise from $0.66 billion in 2019 to $0.78 billion in 2020 at a CAGR of 17.2%.
Price Performance
Over the past year, the stock has gained 4.7% against the industry’s 2.5% decline.
Zacks Rank and Key Picks
Ecolab currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space include Boston Scientific (BSX - Free Report) , DaVita (DVA - Free Report) and Thermo Fisher Scientific (TMO - Free Report) .
DaVita’ long-term earnings growth rate is estimated at 11.9%. The company presently carries a Zacks Rank #1.
Thermo Fisher’s long-term earnings growth rate is estimated at 15.5%. It currently carries a Zacks Rank #2.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Ecolab Disinfectant Gets EPA Nod for Use Against SARS-CoV-2
Ecolab Inc (ECL - Free Report) recently attained product approval from the U.S. Environmental Protection Agency (EPA) for use against SARS-CoV-2, the virus responsible for COVID-19.
Ecolab’s Peroxide Multi Surface Cleaner and Disinfectant is the first EPA-registered disinfectant which has been proven to be effective at killing the SARS-CoV-2 virus and has been approved for use with electrostatic spray technology. This disinfectant is one example of breakthrough solutions powering the new Ecolab Science Certified program.
This is expected to boost Ecolab’s Global Industrial segment.
More on the Product
Utilizing Ecolab’s expertise in hospital hygiene, this proficient disinfectant can be used across several environments, including hospitals, hotels and retail stores. It has been proven to be effective at killing the SARS-CoV-2 virus in only 30 seconds, in both spray bottle and electrostatic spray applications. Among all disinfectants approved for electrostatic spray use, this one is the fastest at killing viruses. No other disinfectant approved for electrostatic spray use has proven effective against the virus causing COVID-19.
When used in an electrostatic spray application, Ecolab’s Peroxide Multi Surface Cleaner and Disinfectant can disinfect large indoor spaces effectively. This industry-leading 3-in-1 peroxide hard-surface cleaner, glass cleaner and disinfectant joins Ecolab’s plethora of disinfectants registered by the EPA as proven effective against SARS-CoV-2.
Apart from this, Ecolab’s Peroxide Multi Surface Cleaner and Disinfectant is convenient to use and offers a streak-free clean across high-touch, hard surfaces and glass. When used manually, it makes the cleaning process simple and lessens the number of cleaning products needed by fusing an effective cleaner and disinfectant into one solution without the requirement to rinse between cleaning and disinfecting.
Recent Developments
This month, Ecolab launched a path-breaking product, Sink & Surface Cleaner Sanitizer, to address unexpected hygiene challenges. It is the first EPA-registered concentrated no-rinse, 2-in-1 cleaner and sanitizer for food contact surfaces that can kill emerging viral pathogens in 30 seconds.
Also recently, the company’s Synergex Sanitizer & Disinfectant became the first product to attain EPA approval for efficiency against biofilms, a complex community of bacteria on food contact surfaces.
Market Prospects
Per a report by ResearchAndMarket.com, the global disinfectants market is projected to rise from $0.66 billion in 2019 to $0.78 billion in 2020 at a CAGR of 17.2%.
Price Performance
Over the past year, the stock has gained 4.7% against the industry’s 2.5% decline.
Zacks Rank and Key Picks
Ecolab currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space include Boston Scientific (BSX - Free Report) , DaVita (DVA - Free Report) and Thermo Fisher Scientific (TMO - Free Report) .
Boston Scientific’s long-term earnings growth rate is estimated at 10%. The company presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DaVita’ long-term earnings growth rate is estimated at 11.9%. The company presently carries a Zacks Rank #1.
Thermo Fisher’s long-term earnings growth rate is estimated at 15.5%. It currently carries a Zacks Rank #2.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>